EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study

Sushmita Banerjee iD, Jayati Sengupta, Rajiv Sinha, Suparna Chatterjee, Subhankar Sarkar, Shakil Akhtar, Rana Saha, Amitava Pahari

Pediatric Nephrology · 2024

DOI: 10.1007/s00467-024-06402-9 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pediatric Nephrology, 2024. Verfasst von Sushmita Banerjee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Institute of Child Health, Kolkata, India. asban444@gmail.com. Hauptthemen laut MEDLINE: Levamisole, Nephrotic Syndrome, Recurrence. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevamisoleNephrotic SyndromeRecurrenceHumansMaleFemaleChildChild, PreschoolTreatment OutcomeDrug Administration ScheduleRemission InductionPrednisoloneAdolescentGlucocorticoids

Stichwörter der Autor:innen

Frequently relapsingLevamisoleNephrotic syndromeNeutropeniaSteroid dependentTransaminitis

Substanzen

LevamisolePrednisoloneGlucocorticoids

Autor:innen und Institutionen

  • Department of Nephrology, Institute of Child Health, Kolkata, India. asban444@gmail.com.
  • Department of Nephrology, Institute of Child Health, Kolkata, India.
  • Department of Pharmacology, Institute of Post Graduate Medical Education & Research, Kolkata, India.

ORCID-Profile: Sushmita Banerjee

Zitieren

APA

Banerjee, S., Sengupta, J., Sinha, R., Chatterjee, S., Sarkar, S., Akhtar, S., Saha, R., & Pahari, A. (2024). Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study. Pediatric Nephrology. https://doi.org/10.1007/s00467-024-06402-9

Vancouver

Banerjee S, Sengupta J, Sinha R, Chatterjee S, Sarkar S, Akhtar S, et al. Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study. Pediatric Nephrology. 2024. doi:10.1007/s00467-024-06402-9

BibTeX
@article{Banerjee2024,
  author = {Banerjee, Sushmita and Sengupta, Jayati and Sinha, Rajiv and Chatterjee, Suparna and Sarkar, Subhankar and Akhtar, Shakil and Saha, Rana and Pahari, Amitava},
  title = {Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study},
  journal = {Pediatric Nephrology},
  year = {2024},
  doi = {10.1007/s00467-024-06402-9}
}
Kostenlos starten →